Homeobox NKX2-3 promotes marginal-zone lymphomagenesis by activating B-cell receptor signalling and shaping lymphocyte dynamics
出版年份 2016 全文链接
标题
Homeobox NKX2-3 promotes marginal-zone lymphomagenesis by activating B-cell receptor signalling and shaping lymphocyte dynamics
作者
关键词
-
出版物
Nature Communications
Volume 7, Issue -, Pages 11889
出版商
Springer Nature
发表日期
2016-06-14
DOI
10.1038/ncomms11889
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The origin and targeting of mucosa-associated lymphoid tissue lymphomas
- (2014) Jose A. Martinez-Climent CURRENT OPINION IN HEMATOLOGY
- Splenic marginal-zone lymphoma: ontogeny and genetics
- (2014) Panagiotis Baliakas et al. LEUKEMIA & LYMPHOMA
- Downregulation of FOXP1 is required during germinal center B-cell function
- (2013) A. Sagardoy et al. BLOOD
- Clonal B-cell lymphocytosis exhibiting immunophenotypic features consistent with a marginal-zone origin: is this a distinct entity?
- (2013) A. Xochelli et al. BLOOD
- NKX2-1/TTF-1: An Enigmatic Oncogene that Functions as a Double-Edged Sword for Cancer Cell Survival and Progression
- (2013) Tomoya Yamaguchi et al. CANCER CELL
- Nkx2-8 Downregulation Promotes Angiogenesis and Activates NF- B in Esophageal Cancer
- (2013) C. Lin et al. CANCER RESEARCH
- B-cell receptor signaling as a driver of lymphoma development and evolution
- (2013) Carsten U. Niemann et al. SEMINARS IN CANCER BIOLOGY
- Chronic inflammation and extra-nodal marginal-zone lymphomas of MALT-type
- (2013) Catherine Thieblemont et al. SEMINARS IN CANCER BIOLOGY
- Pathogenesis of Human B Cell Lymphomas
- (2012) Arthur L. Shaffer et al. Annual Review of Immunology
- High-throughput sequencing analysis of the chromosome 7q32 deletion reveals IRF5 as a potential tumour suppressor in splenic marginal-zone lymphoma
- (2012) Vicente Fresquet et al. BRITISH JOURNAL OF HAEMATOLOGY
- An Integrated Genomic and Expression Analysis of 7q Deletion in Splenic Marginal Zone Lymphoma
- (2012) A. James Watkins et al. PLoS One
- Expression of MALT1 oncogene in hematopoietic stem/progenitor cells recapitulates the pathogenesis of human lymphoma in mice
- (2012) C. Vicente-Duenas et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CXCL13/CXCR5 signaling enhances BCR-triggered B-cell activation by shaping cell dynamics
- (2011) J. Saez de Guinoa et al. BLOOD
- Alteration of BIRC3 and multiple other NF- B pathway genes in splenic marginal zone lymphoma
- (2011) D. Rossi et al. BLOOD
- Integrated Transcript and Genome Analyses Reveal NKX2-1 and MEF2C as Potential Oncogenes in T Cell Acute Lymphoblastic Leukemia
- (2011) Irene Homminga et al. CANCER CELL
- Splenic marginal zone B-cell lymphoma
- (2011) A. Traverse-Glehen et al. CURRENT OPINION IN ONCOLOGY
- Increased expression of NKX2.3 mRNA transcribed from the risk haplotype for ulcerative colitis in the involved colonic mucosa
- (2011) Takashi Arai et al. HUMAN IMMUNOLOGY
- Transcription Factor Nkx2-3 Controls the Vascular Identity and Lymphocyte Homing in the Spleen
- (2011) T. Czompoly et al. JOURNAL OF IMMUNOLOGY
- NKL homeobox genes in leukemia
- (2011) I Homminga et al. LEUKEMIA
- A cyclin-D1 interaction with BAX underlies its oncogenic role and potential as a therapeutic target in mantle cell lymphoma
- (2011) E. Beltran et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The NF- B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas
- (2009) U. Novak et al. BLOOD
- A New Immunostain Algorithm Classifies Diffuse Large B-Cell Lymphoma into Molecular Subtypes with High Accuracy
- (2009) W. W.L. Choi et al. CLINICAL CANCER RESEARCH
- Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease
- (2008) Sheila A Fisher et al. NATURE GENETICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started